Desarrollo y Enfermedades Musculares
DEM
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)
2021
-
Critical review of gaps in the diagnosis and management of drug-induced liver injury associated with severe cutaneous adverse reactions
Journal of Clinical Medicine, Vol. 10, Núm. 22
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Inhibition of the NLRP3 inflammasome prevents ovarian aging
Science Advances, Vol. 7, Núm. 1
-
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Acta Pharmaceutica Sinica B, Vol. 11, Núm. 12, pp. 3685-3726
2017
-
NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction
Oncotarget, Vol. 8, Núm. 59, pp. 99740-99756
2016
-
Amitriptyline induces mitophagy that precedes apoptosis in human HepG2 cells
Genes and Cancer, Vol. 7, Núm. 7-8, pp. 260-277
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222